Regarding the activation level of circulating T-cells in vivo, the portion of activated CD25+ CD4+ helper T-cells showed a significant increase in cancer patients on the first postoperative day (Fig. 4), while the CD25 expressing overall CD3+ cells and CD4− subset did not change significantly in the perioperative course (Additional file 1: Table S1). The gene discussed is CD4; the disease is cancer.